Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX (imPACT)

This study is currently recruiting participants.
Verified October 2013 by University of North Carolina, Chapel Hill
Information provided by (Responsible Party):
David A Wohl, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
First received: June 4, 2012
Last updated: October 9, 2013
Last verified: October 2013

Purpose: The purpose of this study is to determine if a comprehensive intervention supporting seek-test-and-treat results in a significant reduction in the potential for HIV-infected prisoners to transmit their virus after release from prison.

Aim 2: Compare the effect of standard prison test-and-treat (sTNT) with the TNT-imPACT (imPACT) intervention on viral load 24 weeks following prison release.

Aim 3: Describe and model secondary outcomes, comparing them between sTNT and TNT-imPACT study arms. These outcomes include post-release HIV transmission risk behaviors, incident STIs, adherence to ART, medical care appointments, emergence of ART resistance mutations, and predicted HIV transmission events.

Condition Intervention
HIV Infection
Behavioral: Text reminders, counseling, and link coordination
Behavioral: Standard of care - control arm

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)

Resource links provided by NLM:

Further study details as provided by University of North Carolina, Chapel Hill:

Primary Outcome Measures:
  • HIV RNA level (Viral Load) [ Time Frame: Week 24 post-release from prison ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: March 2012
Estimated Study Completion Date: October 2014
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Text reminders, counseling, link coordinator
Text reminders, counseling, link coordination
Behavioral: Text reminders, counseling, and link coordination
This is an intervention with text reminders, counseling that involves motivational interviewing, and link coordination
Active Comparator: Standard of care - control arm Behavioral: Standard of care - control arm
The control arm is standard of care for each subject.

Detailed Description:

For Aims 2 and 3:


We will enroll 400 HIV-infected men and women, age 18 years and older who are incarcerated in the NC Department of Correction (NCDOC) or the Texas Department of Criminal Justice (TDCJ) and scheduled for prison release in approximately 12 weeks, who are receiving ART and have an HIV RNA level that is below 400 copies/mL.

Procedures (methods): Participants will be consented, enrolled, and then randomized 1:1 to one of two conditions:

  1. standard test-and-treat (sTNT), which is the current standard of care, wherein following HIV testing, the DOC provides to HIV-infected inmates ART during incarceration and referral to community-based care and services by prison staff as well as a supply of antiretroviral medication (30 days in NC, 10 in TX) upon release, or
  2. TNT-imPACT (imPACT),which includes the sTNT plus our integrated, multi-component intervention targeting multiple levels to enhance adherence to HIV therapy and linkage to and engagement in clinical care, to maintain viral suppression after release.

All participants will be followed for up to 24 weeks post-release.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Documented HIV infection
  • Incarcerated in the NCDOC at a facility within a 3 hour drive from Chapel Hill OR incarcerated in the TDCJ at a facility within a 3 hour drive from Ft. Worth
  • Age 18 years or older
  • Receiving ART for at least 30 days
  • Last recorded viral load (must be within 90 days of entry) <400 copies/mL
  • English speaking
  • Able and willing to provide informed consent
  • Willing to participate in post-release study activities
  • For NC - planning to remain in state after release and returning to a community within a 3 hour drive of Chapel Hill
  • For TX - returning to one of the following areas: Houston, Dallas, and Ft. Worth (including their suburbs)
  • Scheduled for release from prison

Exclusion Criteria:

  • Conviction for offenses that includes sexual assault or death or serious injury to a victim or is otherwise found, in the opinion of the investigators, to be at high risk for injury to staff (this criterion is designed to minimize risk to study personnel who will conduct study-related visits with participants in the communities to which they return and may be informed by input from correctional staff)
  • Pending charges that would likely lead to transfer of custody or other condition which would otherwise prevent or significantly delay release from custody.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01629316

Contact: Jessica Carda-Auten, MPH 919-966-7759 jessica_carda-auten@med.unc.edu

United States, North Carolina
University of North Carolina at Chapel Hill Recruiting
Chapel Hill, North Carolina, United States, 27514
Contact: Jessica Carda-Auten, MPH    919-966-7759    jessica_carda-auten@med.unc.edu   
Principal Investigator: David Wohl, MD         
Principal Investigator: Carol Golin, MD         
Sub-Investigator: Becky White, MD, MPH         
Sub-Investigator: Stephen Cole, PhD         
Sub-Investigator: David Rosen, MD, PhD         
Sub-Investigator: Roger Akers, PhD         
Sub-Investigator: Catherine Fogel, PhD, RNC         
Sub-Investigator: Sonia Napravnik, PhD         
Sub-Investigator: Kimberly Powers, MSPH         
United States, Texas
Texas Christian University Recruiting
Fort Worth, Texas, United States, 76129
Contact: Michele Gould, MPH    817-257-5926    m.gould@tcu.edu   
Principal Investigator: Patrick Flynn, PhD         
Principal Investigator: Kevin Knight, PhD         
Sponsors and Collaborators
University of North Carolina, Chapel Hill
Principal Investigator: David A Wohl, MD University of North Carolina, Chapel Hill
Principal Investigator: Carol Golin, MD University of North Carolina, Chapel Hill
  More Information

Additional Information:

Responsible Party: David A Wohl, MD, Clinical Associate Professor, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT01629316     History of Changes
Other Study ID Numbers: CID 1007 - UNC IRB 10-1183, R01DA030793-01
Study First Received: June 4, 2012
Last Updated: October 9, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of North Carolina, Chapel Hill:
link coordination
text reminders
motivational interviewing
medication adherence

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on April 17, 2014